These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 23300133)

  • 1. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.
    Chiu CT; Wang Z; Hunsberger JG; Chuang DM
    Pharmacol Rev; 2013 Jan; 65(1):105-42. PubMed ID: 23300133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.
    Wang ZF; Fessler EB; Chuang DM
    Acta Pharmacol Sin; 2011 Dec; 32(12):1433-45. PubMed ID: 22056617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness.
    Manji HK; Moore GJ; Chen G
    Biol Psychiatry; 2000 Oct; 48(8):740-54. PubMed ID: 11063971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.
    Linares GR; Chiu CT; Scheuing L; Leng Y; Liao HM; Maric D; Chuang DM
    Exp Neurol; 2016 Jul; 281():81-92. PubMed ID: 27085395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
    Chuang DM
    Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.
    Missio G; Moreno DH; Demetrio FN; Soeiro-de-Souza MG; Dos Santos Fernandes F; Barros VB; Moreno RA
    Trials; 2019 Oct; 20(1):608. PubMed ID: 31655626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
    Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
    J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium in bipolar mood disorder.
    Dinan TG
    BMJ; 2002 Apr; 324(7344):989-90. PubMed ID: 11976227
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.
    Leng Y; Wang Z; Tsai LK; Leeds P; Fessler EB; Wang J; Chuang DM
    Mol Psychiatry; 2015 Feb; 20(2):215-23. PubMed ID: 24468826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Feng HL; Leng Y; Ma CH; Zhang J; Ren M; Chuang DM
    Neuroscience; 2008 Aug; 155(3):567-72. PubMed ID: 18640245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiapoptotic action of lithium and valproate.
    Bielecka AM; Obuchowicz E
    Pharmacol Rep; 2008; 60(6):771-82. PubMed ID: 19211968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?
    Scheuing L; Chiu CT; Liao HM; Linares GR; Chuang DM
    Int J Biol Sci; 2014; 10(9):1024-38. PubMed ID: 25285035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for a common mechanism of mood stabilizers.
    Harwood AJ; Agam G
    Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium and Valproic Acid in Bipolar Disorders and Beyond.
    Scarselli M
    Curr Neuropharmacol; 2023; 21(4):890. PubMed ID: 37203193
    [No Abstract]   [Full Text] [Related]  

  • 18. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
    Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
    Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.
    Gurvich N; Klein PS
    Pharmacol Ther; 2002 Oct; 96(1):45-66. PubMed ID: 12441177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic evidence for manic episode].
    Terao T
    Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.